Skip to content

Category Archives: Pharmacy Law and Policy

FDA asked to treat superbugs like rare diseases


By Anna Yukhananov WASHINGTON (Reuters) Mar 08 – The Infectious Diseases Society of America is proposing a new approach to the problem of drug-resistant bacteria: turn infections into a rare disease. The group offered a plan on Thursday that would allow the U.S. Food and Drug Administration (FDA) to review certain kinds of antibiotics like […]